Analyze any scale of raw omic or clinical cohorts data using standardized, zero-troubleshooting processing kits. Securely ingest raw datasets in standard formats—including FASTQ, SAM, or VCF sequencing tracks alongside unstructured clinical records—into a centralized cloud data environment.

Eliminate manual pipeline configurations with standardized, pre-configured bioinformatic processing streams that automate raw data normalization, apply strict quality control metrics, mount your active tracks directly onto responsive, interactive genome browser traces for immediate visualization, perform differential analysis, and extract standard omic features.

• 🧬 Supported Modalities: RNA-Seq | ATAC-Seq | ChIP-Seq | Microbiome (16S/Shotgun) | Proteomics | RNA-Protein Interactions (iCLIP) | Spatial | scRNA-Seq | Clinical Biostatistics

2. Go beyond standard bioinformatic analysis by deploying literature-curated workflows to extract complex tertiary features and hidden non-linear molecular patterns. Uncover deep, non-linear biological relationships buried inside your datasets. The platform deploys advanced tertiary analysis tools and machine learning pipelines meticulously curated from top-tier scientific literature, bringing specialized algorithms and pattern-recognition models directly into your execution workspace without manual coding overhead.

• 💡 Examples of Literature-Derived Implementations:
• – From Bulk RNA-Seq: Alternative splicing events, immune cell deconvolution, weighted gene co-expression network analysis (WGCNA), and non-coding RNA mapping.
• – From Single-Cell RNA-Seq: Dynamic CellChat ligand-receptor signaling networks, spatial pattern architectures, and automated, high-fidelity cell-type identification.

🔄 Multi-Modal Clinico-Omic Fusion: Structurally fuse and harmonize completely different types of omic datasets directly with complex patient clinical phenotypes using state-of-the-art predictive integration models.

• 📈 Disease Matrix Expansion: If you only possess a single-omic data track (such as standalone bulk RNA-Seq), the platform automatically cross-references and matches your inputs with Bainom’s pre-compiled Multi-omic Disease Matrix.
• – e.g., by integrating structural-functional DNA/RNA attributes from global baseline repositories, the system infers promoter states, 3’UTR sequence motif enrichments, and predicted protein expression levels for your differentially expressed genes—revealing the exact mechanisms driving your features in disease states versus healthy controls.
• 🌐 Disease Matrix Mining: Cross-reference your extracted molecular features against the Bainom Disease Matrix—a massive repository of clinically actionable signatures pre-extracted from major public and private databanks (including UK Biobank, GEO, and TCGA). Instantly query if your features match your specific study conditions, or run an open-ended global check across every cataloged disease to map overall relevance.
• 🗺️ Deep Cohort Stratification: Match your specific patient profiles directly against global molecular subtyping data. The system dynamically places your samples into large-scale alignment spaces (such as global PCA maps) to instantly determine precise disease subtypes and unlock pre-analyzed structural-functional baseline attributes.

Move directly from complex multiomic data matrices to validated, translational medical assets. Repurpose known drugs and identify novel small molecules by mapping your prioritized pathways or features against global clinical data and known compound interactions.

• 🎯 AI-Driven Feature Prioritization: Validate, shortlist, and rank features based on direct biological significance. The engine utilizes advanced machine learning attention-scoring and automated pathway-network analysis to isolate critical network hubs and biological information flow. Once prioritized, you can turn these candidates into verified biomarkers by training and testing predictive models natively against large-scale clinical metrics like overall patient survival.
• 📄 (b) Drug Repurposing and small molecule ID: Simultaneously run automated drug repurposing pipelines to identify existing therapeutics in use for any disease, uncover their molecular mechanisms, and predict effectiveness against your target features. For novel pipelines, leverage our AI-guided small molecule development engine (protein structure prediction, molecular docking and dynamic simulation, in-silico drug-ligand binding) to accelerate therapeutic discovery.